Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Partial liquid ventilation]

M Quintel1, J Meinhardt, K F Waschke

  • 1Institut für Anästhesiologie und Operative Intensivmedizin, Fakultät für Klinische Medizin Mannheim, Universität Heidelberg.

Der Anaesthesist
|July 24, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Acute renal response to changes in carbon dioxide in mechanically ventilated female pigs.

Physiological reports·2024
Same author

Evaluation of new alternative methods for the identification of estrogenic, androgenic and steroidogenic effects: a comparative in vitro/in silico study.

Archives of toxicology·2023
Same author

Aluminium release and fluid warming: provocational setting and devices at risk.

BMC anesthesiology·2021
Same author

Monitoring lung impedance changes during long-term ventilator-induced lung injury ventilation using electrical impedance tomography.

Physiological measurement·2020
Same author

Noninvasive Neurally Adjusted Ventilator Assist Ventilation in the Postoperative Period Produces Better Patient-Ventilator Synchrony but Not Comfort.

Pulmonary medicine·2020
Same author

The effectiveness of an oral opioid rescue medication algorithm for postoperative pain management compared to PCIA : A cohort analysis.

Der Anaesthesist·2020
Same journal

[Promoting young academics in anesthesiology: factors for an attractive internship].

Der Anaesthesist·2022
Same journal

[Respiratory support in COVID-19: all in due time!]

Der Anaesthesist·2022
Same journal

[Noninvasive respiratory support and invasive ventilation in COVID‑19 : Where do we stand today?]

Der Anaesthesist·2022
Same journal

[Management of acutely decompensated liver cirrhosis in emergency and critical care medicine].

Der Anaesthesist·2022
Same journal

[Anesthesia in patients with acute porphyria].

Der Anaesthesist·2022
Same journal

[Quality and safe anesthesia for all children : That is their right!]

Der Anaesthesist·2022
See all related articles

Partial liquid ventilation (PLV) shows potential for acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) patients under 55, improving ventilator-free days. Further research is needed to confirm benefits and safety in broader populations.

Area of Science:

  • Pulmonary Medicine
  • Critical Care Medicine
  • Biomedical Engineering

Context:

  • Acute Lung Injury (ALI) and Acute Respiratory Distress Syndrome (ARDS) pose significant challenges in critical care.
  • Partial Liquid Ventilation (PLV) is an emerging therapeutic strategy utilizing perfluorocarbons (PFCs).
  • PLV aims to improve gas exchange and lung mechanics in severe respiratory conditions.

Purpose:

  • To evaluate the efficacy and safety of Partial Liquid Ventilation (PLV) in patients with ALI and ARDS.
  • To compare mortality and ventilator-free days (VFDs) between PLV and conventional mechanical ventilation (CMV).
  • To explore the potential benefits of PLV in specific patient subgroups.

Summary:

  • A randomized controlled trial involving 90 adult ALI/ARDS patients found no significant difference in overall mortality or VFDs between PLV and CMV.

Related Experiment Videos

  • Post-hoc analysis revealed a trend towards lower mortality and significantly more VFDs in PLV-treated patients younger than 55.
  • Perfluorocarbons (PFCs) in PLV enhance gas exchange, maintain functional residual capacity (FRC), and reduce alveolar collapse, acting as 'liquid PEEP'.

    • Impact:

    • PLV demonstrates potential as an adjunctive therapy for ALI/ARDS, particularly in younger patients.
    • The unique properties of PFCs offer a novel approach to managing ALI/ARDS pathophysiology.
    • Further research and clinical trials are essential to fully elucidate PLV's role and optimize its application, including combination therapies.